13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001892688-25-000089
Total Value
$266.7M
Positions
18
Other Managers
1
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 1,580,841 | $66.5M | 24.92% |
| 2 | STOKE THERAPEUTICS INC | STOK | 5,187,191 | $57.2M | 21.45% |
| 3 | GH RESEARCH PLC | GHRS | 4,858,994 | $34.0M | 12.75% |
| 4 | C4 THERAPEUTICS INC | CCCC | 6,852,744 | $24.7M | 9.25% |
| 5 | ALLOGENE THERAPEUTICS INC | ALLO | 10,874,723 | $23.2M | 8.68% |
| 6 | TSCAN THERAPEUTICS INC | TCRX | 5,357,347 | $16.3M | 6.11% |
| 7 | CULLINAN THERAPEUTICS INC | CGEM | 1,257,795 | $15.3M | 5.74% |
| 8 | KEROS THERAPEUTICS INC | KROS | 544,001 | $8.6M | 3.23% |
| 9 | PASSAGE BIO INC | PASG | 9,256,953 | $5.2M | 1.97% |
| 10 | ALLAKOS INC | 01671P100 | 3,628,144 | $4.4M | 1.65% |
| 11 | UPSTREAM BIO INC | UPB | 240,042 | $3.9M | 1.48% |
| 12 | PRECISION BIOSCIENCES INC | DTIL | 766,051 | $2.9M | 1.09% |
| 13 | IBIO INC | IBIO | 862,279 | $2.1M | 0.79% |
| 14 | CARIBOU BIOSCIENCES INC | CRBU | 680,189 | $1.1M | 0.41% |
| 15 | VOR BIOPHARMA INC | VOR | 637,218 | $707,312 | 0.27% |
| 16 | CENTESSA PHARMACEUTICALS PLC | CNTA | 17,400 | $291,450 | 0.11% |
| 17 | NEUPHORIA THERAPEUTICS INC | NEUP | 45,806 | $157,115 | 0.06% |
| 18 | REPARE THERAPEUTICS INC | 760273102 | 79,176 | $103,721 | 0.04% |